TLRY Tilray Brands Tilray Brands continues to reduce its debt. German prescriptions and new patients have gone through the roof since legalization. Tilray Brands commanded double digit market share of Germany's medical cannabis industry prior to legalization. Piller 2 of German legalization already being pushed forward and recreational sales in the country will kick off far sooner then many expected. On the domestic front many Canadian smaller companies unfortunately have exited the market but not so unfortunate for TLRY which remains paid up on all taxes. More market share opening up for Tilray Brands in Canada. South of the border TLRY continues to execute on its synergies moving production in house on its newly acquired brands from InBev. This will increase margins on par with the legacy businesses to above 45 percent. Recent Analysis chimed in on TLRY as a buy with the market failing to assign proper value on its growing alcohol revenue and medical implications in the USA upon rescheduling or maybe even descheduling all together. Germany Germany Germany TLRY brands.